Zynex, Inc. (ZYXI)

Market Cap	77.55M
Revenue (ttm)	192.35M
Net Income (ttm)	2.99M
Shares Out	31.91M
EPS (ttm)	0.09
PE Ratio	27.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	217,803
Open	2.440
Previous Close	2.460
Day's Range	2.360 - 2.470
52-Week Range	2.360 - 12.840
Beta	0.81
Analysts	Buy
Price Target	10.25 (+321.81%)
Earnings Date	Mar 11, 2025

About ZYXI

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology de...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1996
• Employees: 1,000
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYXI
• Website: https://www.zynex.com

Financial Performance

In 2024, Zynex's revenue was $192.35 million, an increase of 4.36% compared to the previous year's $184.32 million. Earnings were $2.99 million, a decrease of -69.24%.

Analyst Forecast

According to 3 analysts, the average rating for ZYXI stock is "Buy." The 12-month stock price forecast is $10.25, which is an increase of 321.81% from the latest price.

Price Target

$10.25

(321.81% upside)

Analyst Consensus: Buy